FDA approves Mylotarg to treat acute myeloid leukemia

The U.S. Food and Drug Administration approved Mylotarg, or gemtuzumab, for the treatment of adults with newly diagnosed acute myloid leukemia.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news